Header Logo

Connection

Kyle Amber to Molecular Targeted Therapy

This is a "connection" page, showing publications Kyle Amber has written about Molecular Targeted Therapy.
Connection Strength

0.611
  1. Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548.
    View in: PubMed
    Score: 0.611
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.